Nestlé: the Maggi noodles ban in India and the road back

The situation

On 5 June 2015 India’s food regulator, the Food Safety and Standards Authority of India (FSSAI), ordered Nestlé India to stop selling Maggi instant noodles and to pull every variant from the shelves. The order covered all nine versions of the product. FSSAI said lab tests had found lead above the permitted limit and monosodium glutamate (MSG) that the packaging did not declare. Nestlé India had told the public for years that Maggi was safe, and it still said so. It nevertheless withdrew the product from the market the same day, while it went to court to fight the order.

The numbers explain why this was a crisis and not a recall. Maggi was reported to hold nearly 70 per cent of the Indian instant noodles market and to account for close to 30 per cent of the company’s revenue. Its annual sales were put at about Rs 1,500 crore (roughly US$240 million). Nestlé India itself estimated that the stock to be destroyed was worth about Rs 320 crore. In the quarter that followed it posted its first quarterly loss in nearly 30 years, a loss of Rs 64.40 crore against a profit of Rs 287.86 crore a year earlier.

The case is useful because it combines three problems that rarely arrive together: a regulator whose test results were later criticised by a court, a consumer panic that did not wait for the legal argument, and a brand so dominant that its absence reshaped a whole category. Maggi returned to shelves in November 2015, about five months later, and by August 2016 Nestlé said it had won back the leading share. The legal argument lasted far longer than the commercial one. A government damages claim of about Rs 640 crore was dismissed only in April 2024.

Background

A company built on a single product habit

Nestlé India is the Indian arm of the Swiss food group. At the time of the ban it ran eight factories and employed nearly 7,200 people, according to press reports of the period. Maggi was the company’s fastest-selling food item in India. The product had become a household name in a way few packaged foods manage: a quick meal made at home. That habit is what made the brand so valuable, and a public safety scare about it was bound to reach a very large number of households.

The company’s earnings leaned heavily on it. Reports at the time put Maggi at nearly 30 per cent of revenue. A business with that much of its income in one brand has little room to absorb a long absence of that brand. The sources opened for this case do not break down the rest of the range, but nothing suggests another product could replace Maggi volumes quickly.

How the trouble started

The first tests came before the national order. Al Jazeera reported that lab tests ordered by some state governments in April 2015 found MSG that was not on the ingredient list. Samples from Uttar Pradesh were cited in later reports, and a central laboratory in Kolkata was reported to have found lead at 17.2 parts per million in one sample, against a legal maximum of 2.5 ppm. FSSAI also objected to the “no added MSG” claim on the pack, because it took the view that the noodles’ flavouring contained a flavour enhancer.

Nestlé India said that its own testing disagreed. It said more than 2,700 samples had been tested by accredited laboratories in India and abroad and that each had shown lead far below the permitted level. The two sides were therefore arguing about method and about whose laboratory counted, as much as about the noodles themselves.

The company’s position before the order

Nestlé India was a long-established, well-regarded food company with a reputation for quality. That reputation made the shock larger. It also meant that the company’s first instinct was to defend the product on the science. The managing director at the time, Etienne Benet, was recalled by the parent company on 24 July 2015, and Suresh Narayanan became managing director on 1 August. The chairman, Antonio Helio Waszyk, retired on 1 October. Nestlé’s reaction was therefore also a story of leadership change in the middle of a crisis.

The industry

Instant noodles and the packaged food market

Instant noodles in India were close to a one-brand category in 2015. With Maggi at roughly 70 per cent of the market, rivals were small and the category’s habits were Maggi’s habits. One named competitor was Hindustan Unilever, which sold Knorr Chinese noodles. A gap on the shelf was therefore an opening for any rival with product and distribution ready.

Regulation: a young regime with strong powers

FSSAI works under the Food Safety and Standards Act, 2006. It sets standards, approves products and can order a withdrawal. The Maggi order showed how strong that power was and how hurried its use could be. In the same month, Hindustan Unilever stopped selling its Knorr Chinese instant noodle range. HUL said the reason was not safety. It had applied to FSSAI for product approval in February 2015, the application was still pending, and it chose to stop production and sale until approval came. It said additional tests at an FSSAI-approved external laboratory had found the noodles safe and compliant. The episode shows that product approval rules were being applied more tightly across the category, not only to Nestlé.

Trust and word of mouth

Packaged food depends on a quiet assumption that a product on a shop shelf has been checked. When a regulator calls a product “unsafe and hazardous”, that assumption fails for the whole brand, whatever later laboratory work shows. Nestlé was operating in a market where public concern could move faster than any laboratory could.

Export exposure

Nestlé India exported Maggi to markets including the US, Canada, the UK, Australia, Singapore and Kenya. In June 2015 the authorities in Canada, the US and the UK were reported to be looking into the concerns, while Singapore had cleared the product. The US Food and Drug Administration later said that its own tests found lead within acceptable levels for US consumers. This mattered because it showed regulators elsewhere reading the same product differently, which Nestlé used in its arguments.

The decision

The company’s decision was not whether to comply, since the order was legally binding, but how. Every option involved a trade between protecting the facts, the brand and the relationship with the regulator. The options below are the obvious alternatives, framed as such. The press reports do not show Nestlé’s internal deliberations, so this section describes the choices on the table, not a minute of a board meeting.

Option one: fight the order and keep selling

Nestlé could have kept the product in the market while it contested the order in court. That would have protected sales for a few weeks. It would also have meant selling a product that the national regulator had called unsafe, in the face of a spreading public panic, and risking a breach of the order. The damage to trust from that stance would have been hard to repair.

Option two: withdraw and litigate at once

The second path was to pull the product voluntarily, comply with the order, and challenge it before the Bombay High Court. This is what the company did. It kept its claim that the product was safe, which protected its position in the legal fight, while removing the visible risk to customers. The price was the immediate loss of the revenue and the cost of destroying stock.

Option three: accept the findings and reformulate

A third route would have been to accept that the regulator’s results were right, quietly reformulate, and relaunch. That would have been faster in theory. It would also have been an admission, would have undermined the argument that the product was safe, and would have exposed Nestlé to the consumer claims that the government was preparing. The company’s repeated statements that the noodles were safe, and the later court findings about the testing, suggest this was never a serious option.

What was at stake

Beyond the revenue, the stake was the company’s licence to operate in packaged food. A company that is seen to have hidden a defect rarely recovers. A company that is seen to have been treated unfairly can recover, provided that it shows respect for consumers while it argues. The decision to withdraw while contesting the order tried to hold both positions.

What they did

5 June 2015: withdrawal despite a safety claim

On the day of the FSSAI order, Nestlé withdrew Maggi from the shelves. The company said the move came amid growing consumer confusion, even though it still held that the product was safe. Its chief executive said that day that he was confident Maggi would return “very soon”. That confidence turned out to be optimistic by several months.

June 2015: counting and destroying the stock

Nestlé India estimated the value of the withdrawn product at about Rs 320 crore. Of that, about Rs 210 crore was the sales value of stock in the market, including stock held by trade partners, and about Rs 110 crore was the value of noodles and related materials in factories and distribution centres. The company called these broad estimates and said that collecting, moving and destroying the stock would add costs. DNA reported that about 30,000 tonnes were destroyed. Business Today, citing a PTI report, said Nestlé India was believed to have paid Rs 20 crore to Ambuja Cements to burn the stock at its plant in Chandrapur, Maharashtra. The company would not confirm that figure.

June to August 2015: the court case

Nestlé challenged the ban in the Bombay High Court. In mid-June the court left the ban in place for the time being and set a further hearing. The government separately moved towards a legal claim. The day before the final ruling, India said it was seeking nearly US$100 million in damages for unfair trade practices. The Consumer Affairs Ministry brought its case before the National Consumer Disputes Redressal Commission (NCDRC), the first use of a provision of the Consumer Protection Act that lets the Centre and states file such complaints.

13 August 2015: the High Court ruling

Justice Vidyasagar Kanade set aside the ban. The court called the regulator’s action arbitrary and said it breached the principles of natural justice, because Nestlé had not been given a fair hearing before the order. It also found that the laboratories the regulator had relied on did not meet the requirements of the Food Safety and Standards Act and its rules. FSSAI had said 30 of 72 samples showed high lead. The court did not simply clear the product. It ordered Nestlé to send five samples from each batch to three accredited laboratories and allowed production and sales to restart only if lead was within the limit. The report said Nestlé had six weeks to run those tests.

August to November 2015: management and marketing

During the wait, Nestlé changed its leadership and kept the brand visible. It ran a campaign called #WeMissYouToo, reported by DNA India. The aim was to keep goodwill alive while there was nothing to sell. The company said it would not cut jobs, though factories stood nearly idle. At Moga in Punjab, which normally employed about 1,000 contract workers plus regular staff, only about 200 people were reported at work during the ban.

9 November 2015: relaunch

Nestlé relaunched Maggi Masala noodles on 9 November 2015, after accredited laboratories had cleared all the tested samples, as the court had required. Production resumed at three plants first: Nanjangud in Karnataka, Moga in Punjab and Bicholim in Goa. The company followed with an aggressive advertising push. In 2016 it also launched up to 25 products in a single day, according to Business Today, to counter competition and reduce its reliance on one brand.

What happened

The financial hit

The financial effect arrived in stages. In the quarter to June 2015, reported on 29 July, net sales fell 20.1 per cent. Sales of Rs 288.4 crore were reversed for Maggi already sold and then withdrawn, and the company booked an exceptional item of Rs 451.66 crore for losses on withdrawn stock and related costs. The result was a standalone loss of Rs 64.40 crore.

For the full year, exceptional items were Rs 501 crore and Rs 303.4 crore of sales were reversed. Nestlé India said the Maggi issue affected the second, third and fourth quarters, so 2015 could not be compared cleanly with earlier years. The fourth quarter still showed net sales down 22.6 per cent, which tells us that the relaunch in November did not repair the quarter.

The share price

The market was more forgiving than the profit line. According to DNA, the share fell to Rs 5,539.80 on 8 June 2015, its low for the year, and had recovered to Rs 6,831.95 by 5 August, the highest since the ban. Investors were treating the loss as temporary. The shares closed at Rs 6,147.30 on the day the first loss was reported.

Recovery of share

In August 2016 Nestlé said that it had regained the leading market share in India and that growth had turned positive in June 2016, crediting the Maggi relaunch and easy comparisons with the weak 2015 base. The company’s own wording also credits favourable comparables, which means part of the reported rebound is arithmetic, not only recovery.

The legal tail

The legal fight continued after the commercial one had largely finished. On 13 January 2016 the Supreme Court stayed the NCDRC proceedings and asked the Central Food Technological Research Institute (CFTRI) in Mysuru to test the product. On 11 April 2016 the institute reported that the 29 samples it tested had lead within permissible limits. On 3 January 2019 the Supreme Court revived the government’s case, saying the CFTRI report would form its basis. The Consumer Affairs Ministry’s claim had two parts, about Rs 284 crore in compensation and about Rs 355 crore in punitive damages, a total near Rs 640 crore. Reports give slightly different figures for the two parts. According to a report in April 2024, citing Nestlé’s regulatory filings, the NCDRC dismissed the complaint by an order dated 2 April 2024.

Other views

The regulator and the government

FSSAI’s case was that lead and undeclared MSG made the product unsafe and the labelling misleading. The Consumer Affairs Ministry added a claim that Nestlé had misled consumers by promoting Maggi as healthy, using the slogan “Taste bhi healthy bhi”. From the regulator’s side, acting fast on a food safety signal is what a regulator is for, and The weakness was in the process, which the Bombay High Court described as arbitrary.

Nestlé

Nestlé India said throughout that the noodles were safe, pointing to thousands of tests by accredited laboratories. Its argument won on procedure in August 2015 and on the later CFTRI result. Its critics would say that a company that sells to millions of children should have caught the labelling problem on MSG earlier, and the ban order did cite the “no added MSG” claim. The court case did not settle that point as a matter of public perception.

Competitors

Hindustan Unilever’s decision to stop its Knorr Chinese range was presented as a response to a pending approval, not a safety problem. Rivals gained a short opening in the weeks Maggi was missing, but the reports available do not show any one competitor holding the gain once Maggi returned.

Limits of the evidence

Several figures come from company estimates or from press agency reports that attribute them to unnamed sources, including the Rs 20 crore paid for destruction. Market share figures for Maggi before and after the ban are approximate, and the public reports do not give a precise share for 2016. Figures for the legal claim differ slightly between outlets.

Reading it through a framework

Stakeholder mapping

The crisis involved at least six groups with different power and different interests. Consumers held the final say, because they decide what to buy. The regulator held legal power. The courts held the power to review the regulator. The Consumer Affairs Ministry held a separate power to claim damages. Retailers and distributors carried stock and credit. Employees and contract workers carried the idle plants. Nestlé’s early moves paid attention to the legal stakeholders and to consumers, and its advertising during the ban addressed consumer goodwill. A reader can test the case by asking which stakeholder was handled well and which was handled late. The leadership change in July and August looks like a recognition that the company’s relationship with Indian institutions needed new people.

Brand equity and single-product risk

A strong brand lets a company charge for trust. It also concentrates risk. Maggi supplied close to 30 per cent of revenue and almost 70 per cent of its category, so one regulatory finding reached the whole business. The 2016 launch of up to 25 products in one day reads as a response to that exposure. The framework also helps explain the recovery. Accumulated trust is a store of value, and decades of use appear to have let customers forgive the company once the legal doubt lifted, though the share data say that the forgiveness was not complete in the first year.

Since then

Maggi stayed on sale and Nestlé India recovered its sales and profit in the following years, though the reports opened for this case do not give figures for later years, so none are given here. The legal story ended much later. After the Supreme Court revived the damages case in January 2019, the NCDRC dismissed the government’s complaint by an order dated 2 April 2024, as reported on 4 April 2024. That result closed the last major claim linked to the 2015 ban, nearly nine years after the order that began it.

Suresh Narayanan, who became managing director on 1 August 2015, was later appointed chairman, as announced with the July to September 2015 results. The leadership team brought in during the crisis therefore stayed on to lead the company through the recovery.

What to take from it

• A company can be right on the science and still lose months of sales, because consumers act on the regulator’s headline, not on the court’s later reasoning.
• Withdrawing a product while contesting the order protected both the customer relationship and the legal position, and the cost of that choice was a first loss in nearly 30 years.
• Concentration in one brand turns a single regulatory finding into a company-wide event, which is why Nestlé moved quickly to widen its product range after the relaunch.
• Process matters in regulation: the Bombay High Court set the ban aside because of the lack of a fair hearing and of properly accredited laboratories, not because it declared the product safe.
• Recovery figures need careful reading, because part of the 2016 rebound came from a weak 2015 base, as Nestlé itself said.

Questions to think about

1. Nestlé withdrew a product it believed was safe. Under what conditions would a company be right to keep selling while it argues its case?
2. How should a company weigh a regulator’s speed against a regulator’s accuracy when its own brand is the subject?
3. If Maggi had held 30 per cent of its category instead of 70 per cent, which parts of the story would have changed?
4. What would a consumer need to see to believe a retest by the company’s own chosen laboratories?

Concepts at work

This case shows stakeholder mapping, single-product concentration risk and crisis communication. Explore them in Insights.

Written from the public sources listed below. Figures are as those sources report them.